Asset
BATOCLIMAB
Revenue
No revenue reported in loaded filings.
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03863080 | phase2 | completed | 2019-05-21 | 2020-10-07 | Immunovant Sciences GmbH | A Study of RVT-1401 in Myasthenia Gravis (MG) Patients |
| NCT03938545 | phase2 | terminated | 2019-07-23 | 2021-02-02 | Immunovant Sciences GmbH | ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO ) |
| NCT03922321 | phase2 | completed | 2019-04-22 | 2020-02-29 | Immunovant Sciences GmbH | Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO) |
| NCT04253236 | phase2 | terminated | 2020-08-11 | 2021-04-01 | Immunovant Sciences GmbH | To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA). |
FDA applications (0)
This company has no applications containing this asset.